Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
MAXONA Pharmaceuticals logo — Maxona pharmaceuticals is committed to leveraging an ex-u

MAXONA Pharmaceuticals

Maxona pharmaceuticals is committed to leveraging an ex-u

Founded 2016 United States Malvern, United States 9 employees Total: $5.60M Biotechnology, Health Care +3

General Information

Company Name MAXONA Pharmaceuticals
Founded Year 2016
Location United States Malvern, United States
Employees 9
Industries Biotechnology, Health Care, Health and Wellness +2
Social

BounceWatch is an independent company data service, not affiliated with MAXONA Pharmaceuticals. To contact MAXONA Pharmaceuticals, visit maxonapharm.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MAXONA Pharmaceuticals compare?

A PDF of MAXONA Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MAXONA Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MAXONA Pharmaceuticals

MAXONA Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company leveraging innovation to develop the next generation of therapies to help patients maximize life. MAXONA's initial focus is on addressing the urgent need for new effective therapies that treat acute and chronic pain, without the side effects and addiction risks associated with NSAIDS and opioids. MAXONA's lead compound, MAX-001 is a non-opioid, non-NSAID oral therapy with a novel mechanism of action that is initially being developed in the U.S. to treat acute and chronic pain. MAX-001 is a patent protected optimized formulation of nefopam. which is widely used and extensively studied outside the U.S. to treat acute and chronic pain. MAXONA has assembled a highly experienced and well recognized leadership team with a proven record of successfully developing and commercializing effective therapeutics. With deep experience in all areas of clinical development and commercialization, the leadership team is well-equipped to realize MAXONA's vision to help patients maximize life.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC $5.60M -
01 May 2021

MAXONA Pharmaceuticals Alternatives & Competitors

View All Alternatives
MAXONA Pharmaceuticals vs
Neumentum, Inc.
Neumentum, Inc. United States

Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceut...

Venture round
6 employees
Biotechnology, Health Care
MAXONA Pharmaceuticals vs
Semnur Pharmaceuticals, Inc.
Semnur Pharmaceuticals, Inc. United States

Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and comme...

Venture round
2 employees
Biotechnology, Pharmaceutical
MAXONA Pharmaceuticals vs
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. United States

Uniquely poised to disrupt pain therapy.

Series B
57 employees
Biotechnology, Health Care
Also compare with: MAXONA Pharmaceuticals vs Pacira BioSciences, Inc. Pacira BioSciences, Inc. View all alternatives

FAQ About MAXONA Pharmaceuticals

Maxona pharmaceuticals is committed to leveraging an ex-u
MAXONA Pharmaceuticals was founded in 2016.
MAXONA Pharmaceuticals is headquartered in Malvern, United States.
MAXONA Pharmaceuticals operates in Biotechnology, Health Care, Health and Wellness, Life Sciences and Pharmaceutical.
MAXONA Pharmaceuticals has approximately 9 employees.
MAXONA Pharmaceuticals has completed 1 funding round, raising a total of $5.60M.
Top alternatives and competitors to MAXONA Pharmaceuticals include Neumentum, Inc., Semnur Pharmaceuticals, Inc., Latigo Biotherapeutics, Inc., Pacira BioSciences, Inc., Enalare Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MAXONA Pharmaceuticals and Neumentum, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MAXONA Pharmaceuticals, https://bouncewatch.com/company/maxona-pharmaceuticals, updated 9 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout